BIOMAT Database Logo BIOMAT Database Logo

Expression of major histocompatibility complex class II antigens on bile duct epithelium in patients with hepatic graft-versus-host disease after bone marrow transplantation. 1987

F Miglio, and M Pignatelli, and V Mazzeo, and M Baraldini, and G F Stefanini, and G Guardigli, and G Bandini, and P Ricci, and S Tura, and G Gasbarrini
Patologia Medica I, University of Bologna, Italy.

We studied the expression of major histocompatibility complex (MHC) class II antigens in liver biopsies taken from ten patients with clinical and biochemical evidence of liver damage after bone marrow transplantation. In all six patients who had histologically confirmed graft-versus-host disease, MHC class II antigens were detected on intrahepatic bile ducts. In four patients with no histological features of graft-versus-host disease, MHC class II antigens were not detected. In controls, a positive reaction for bile duct MHC class II antigens was only detected in the patients with primary biliary cirrhosis. Characterisation of the lymphocytes surrounding the bile ducts showed a prevalence of Leu 3+ cells in graft-versus-host disease and primary biliary cirrhosis. We propose that the aberrant expression of class II antigens on bile duct epithelium cells may play a role in the pathogenesis of graft-versus-host disease. A similar pattern in primary biliary cirrhosis may suggest a common pathogenetic mechanism.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008107 Liver Diseases Pathological processes of the LIVER. Liver Dysfunction,Disease, Liver,Diseases, Liver,Dysfunction, Liver,Dysfunctions, Liver,Liver Disease,Liver Dysfunctions
D008285 Major Histocompatibility Complex The genetic region which contains the loci of genes which determine the structure of the serologically defined (SD) and lymphocyte-defined (LD) TRANSPLANTATION ANTIGENS, genes which control the structure of the IMMUNE RESPONSE-ASSOCIATED ANTIGENS, HUMAN; the IMMUNE RESPONSE GENES which control the ability of an animal to respond immunologically to antigenic stimuli, and genes which determine the structure and/or level of the first four components of complement. Histocompatibility Complex,Complex, Histocompatibility,Complex, Major Histocompatibility,Complices, Histocompatibility,Complices, Major Histocompatibility,Histocompatibility Complex, Major,Histocompatibility Complices,Histocompatibility Complices, Major,Major Histocompatibility Complices
D008297 Male Males
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D004848 Epithelium The layers of EPITHELIAL CELLS which cover the inner and outer surfaces of the cutaneous, mucus, and serous tissues and glands of the body. Mesothelium,Epithelial Tissue,Mesothelial Tissue,Epithelial Tissues,Mesothelial Tissues,Tissue, Epithelial,Tissue, Mesothelial,Tissues, Epithelial,Tissues, Mesothelial
D005260 Female Females
D006086 Graft vs Host Disease The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION. Graft-Versus-Host Disease,Homologous Wasting Disease,Runt Disease,Graft-vs-Host Disease,Disease, Graft-Versus-Host,Disease, Graft-vs-Host,Disease, Homologous Wasting,Disease, Runt,Diseases, Graft-Versus-Host,Diseases, Graft-vs-Host,Graft Versus Host Disease,Graft-Versus-Host Diseases,Graft-vs-Host Diseases
D006649 Histocompatibility Antigens A group of antigens that includes both the major and minor histocompatibility antigens. The former are genetically determined by the major histocompatibility complex. They determine tissue type for transplantation and cause allograft rejections. The latter are systems of allelic alloantigens that can cause weak transplant rejection. Transplantation Antigens,Antigens, Transplantation,Histocompatibility Antigen,LD Antigens,SD Antigens,Antigen, Histocompatibility,Antigens, Histocompatibility,Antigens, LD,Antigens, SD
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

F Miglio, and M Pignatelli, and V Mazzeo, and M Baraldini, and G F Stefanini, and G Guardigli, and G Bandini, and P Ricci, and S Tura, and G Gasbarrini
Expression of MHC class II antigens on bile duct epithelium in experimental graft versus host disease.
June 1985, Clinical and experimental immunology,
F Miglio, and M Pignatelli, and V Mazzeo, and M Baraldini, and G F Stefanini, and G Guardigli, and G Bandini, and P Ricci, and S Tura, and G Gasbarrini
Effects of non-major histocompatibility antigens on acute graft-versus-host reaction after allogeneic bone marrow transplantation.
August 1997, Bone marrow transplantation,
F Miglio, and M Pignatelli, and V Mazzeo, and M Baraldini, and G F Stefanini, and G Guardigli, and G Bandini, and P Ricci, and S Tura, and G Gasbarrini
Influence of endotoxin on graft-versus-host disease after bone marrow transplantation across major histocompatibility barriers in mice.
May 1987, Transplantation,
F Miglio, and M Pignatelli, and V Mazzeo, and M Baraldini, and G F Stefanini, and G Guardigli, and G Bandini, and P Ricci, and S Tura, and G Gasbarrini
Expression of class I and class II major histocompatibility complex antigens on oral mucosal epithelium.
March 1987, Journal of oral pathology,
F Miglio, and M Pignatelli, and V Mazzeo, and M Baraldini, and G F Stefanini, and G Guardigli, and G Bandini, and P Ricci, and S Tura, and G Gasbarrini
Bone Marrow Graft-Versus-Host Disease in Major Histocompatibility Complex-Matched Murine Reduced-Intensity Allogeneic Hemopoietic Cell Transplantation.
November 2017, Transplantation,
F Miglio, and M Pignatelli, and V Mazzeo, and M Baraldini, and G F Stefanini, and G Guardigli, and G Bandini, and P Ricci, and S Tura, and G Gasbarrini
Immune tolerance to self-major histocompatibility complex class II antigens after bone marrow transplantation: role of regulatory T cells.
May 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation,
F Miglio, and M Pignatelli, and V Mazzeo, and M Baraldini, and G F Stefanini, and G Guardigli, and G Bandini, and P Ricci, and S Tura, and G Gasbarrini
Bile regulates the expression of major histocompatibility complex class II molecules on rat intestinal epithelium.
December 1997, Gastroenterology,
F Miglio, and M Pignatelli, and V Mazzeo, and M Baraldini, and G F Stefanini, and G Guardigli, and G Bandini, and P Ricci, and S Tura, and G Gasbarrini
Major histocompatibility complex expression in brain of rats with graft-versus-host disease.
June 1991, Journal of neuroimmunology,
F Miglio, and M Pignatelli, and V Mazzeo, and M Baraldini, and G F Stefanini, and G Guardigli, and G Bandini, and P Ricci, and S Tura, and G Gasbarrini
Major histocompatibility complex expression in muscle of rats with graft-versus-host disease.
January 1996, Histology and histopathology,
F Miglio, and M Pignatelli, and V Mazzeo, and M Baraldini, and G F Stefanini, and G Guardigli, and G Bandini, and P Ricci, and S Tura, and G Gasbarrini
Role of major histocompatibility complex variation in graft-versus-host disease after hematopoietic cell transplantation.
January 2017, F1000Research,
Copied contents to your clipboard!